Divi's Laboratories Ltd (Divi) manufactures and supplies Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Divi has taken several R&D initiatives, essentially through its research centers known as Divi’s Research Center (DRC) at Sanath Nagar, Hyderabad, and Process Development & Support Centers (PDSCs) at Hyderabad and Visakhapatnam. These centers work on the development of processes for new compounds and the improvement of processes for compounds already on the market. The company has 3 R&D centers and about 18,300 employees across the Company. The PDSCs also work on process development and scale-up from gram scale through various stages of development, process optimization, impurity profile, pilot studies, pre-validation batches, validation of process, and transfer of technology to the plant. They also review and improve processes and provide process support to the plants periodically. In FY2024, the company spent INR800 million on its R&D activities, which as a percentage of revenue stood at 0.9%.